Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability
- 28 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 127 (6), 811-823
- https://doi.org/10.1161/circresaha.120.316743
Abstract
Download figure Download PowerPoint Rationale: Arterial inflammation manifested as atherosclerosis is the leading cause of mortality worldwide. Genome-wide association studies have identified a prominent role of HDAC (histone deacetylase)-9 in atherosclerosis and its clinical complications including stroke and myocardial infarction. Objective: To determine the mechanisms linking HDAC9 to these vascular pathologies and explore its therapeutic potential for atheroprotection. Methods and Results: We studied the effects of Hdac9 on features of plaque vulnerability using bone marrow reconstitution experiments and pharmacological targeting with a small molecule inhibitor in hyperlipidemic mice. We further used 2-photon and intravital microscopy to study endothelial activation and leukocyte-endothelial interactions. We show that hematopoietic Hdac9 deficiency reduces lesional macrophage content while increasing fibrous cap thickness thus conferring plaque stability. We demonstrate that HDAC9 binds to IKK (inhibitory kappa B kinase)-α and β, resulting in their deacetylation and subsequent activation, which drives inflammatory responses in both macrophages and endothelial cells. Pharmacological inhibition of HDAC9 with the class IIa HDAC inhibitor TMP195 attenuates lesion formation by reducing endothelial activation and leukocyte recruitment along with limiting proinflammatory responses in macrophages. Transcriptional profiling using RNA sequencing revealed that TMP195 downregulates key inflammatory pathways consistent with inhibitory effects on IKKβ. TMP195 mitigates the progression of established lesions and inhibits the infiltration of inflammatory cells. Moreover, TMP195 diminishes features of plaque vulnerability and thereby enhances plaque stability in advanced lesions. Ex vivo treatment of monocytes from patients with established atherosclerosis reduced the production of inflammatory cytokines including IL (interleukin)-1β and IL-6. Conclusions: Our findings identify HDAC9 as a regulator of atherosclerotic plaque stability and IKK activation thus providing a mechanistic explanation for the prominence of HDAC9 as a vascular risk locus in genome-wide association studies. Its therapeutic inhibition may provide a potent lever to alleviate vascular inflammation. Graphical A graphical abstract is available for this article.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (CRC 1123 [B3,A3,A6,B5,Z1); SyNergy)
This publication has 54 references indexed in Scilit:
- Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17–92 Cluster in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Large-scale association analysis identifies new risk loci for coronary artery diseaseNature Genetics, 2012
- Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic strokeNature Genetics, 2012
- Histone deacetylases as regulators of inflammation and immunityTrends in Immunology, 2011
- Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKεNucleic Acids Research, 2010
- Histone Deacetylase 3 Is Critical in Endothelial Survival and Atherosclerosis Development in Response to Disturbed FlowCirculation, 2010
- Acetylation of MEK2 and IκB kinase (IKK) activation loop residues by YopJ inhibits signalingProceedings of the National Academy of Sciences of the United States of America, 2006
- Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005